NEA Management Company as of Sept. 30, 2015
Portfolio Holdings for NEA Management Company
NEA Management Company holds 35 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tesaro | 23.4 | $355M | 8.9M | 40.10 | |
| Ardelyx (ARDX) | 11.7 | $178M | 10M | 17.28 | |
| Groupon | 9.5 | $144M | 44M | 3.26 | |
| Supernus Pharmaceuticals (SUPN) | 7.1 | $107M | 7.6M | 14.03 | |
| Clovis Oncology | 6.9 | $105M | 1.1M | 91.96 | |
| Dermira | 5.4 | $82M | 3.5M | 23.34 | |
| Opower | 5.3 | $80M | 9.0M | 8.91 | |
| Epizyme | 4.4 | $66M | 5.1M | 12.86 | |
| Trevena | 3.3 | $50M | 4.8M | 10.35 | |
| Glycomimetics (GLYC) | 3.2 | $48M | 8.6M | 5.60 | |
| Nevro (NVRO) | 3.0 | $46M | 993k | 46.39 | |
| Loxo Oncology | 2.1 | $31M | 1.8M | 17.48 | |
| Aerohive Networks | 1.8 | $28M | 4.7M | 5.98 | |
| Lexicon Pharmaceuticals | 1.7 | $26M | 2.4M | 10.74 | |
| Trivascular Technologies | 1.3 | $20M | 3.9M | 5.00 | |
| Tracon Pharmaceuticals | 1.2 | $19M | 1.9M | 9.77 | |
| Care | 1.1 | $17M | 3.3M | 5.14 | |
| Millennial Media | 0.9 | $14M | 8.2M | 1.75 | |
| Exelixis (EXEL) | 0.8 | $12M | 2.2M | 5.61 | |
| Zosano Pharma | 0.6 | $8.5M | 2.2M | 3.96 | |
| Champions Oncology (CSBR) | 0.6 | $8.4M | 1.6M | 5.35 | |
| Cvent | 0.5 | $8.2M | 244k | 33.66 | |
| Rigel Pharmaceuticals (RIGL) | 0.5 | $8.0M | 3.2M | 2.47 | |
| Orexigen Therapeutics | 0.5 | $7.8M | 3.7M | 2.11 | |
| Aurinia Pharmaceuticals (AUPH) | 0.5 | $7.2M | 2.5M | 2.84 | |
| Arca Biopharma | 0.5 | $7.2M | 1.5M | 4.96 | |
| Zhone Technologies | 0.4 | $6.6M | 4.8M | 1.37 | |
| Roka Bioscience | 0.4 | $6.3M | 3.2M | 1.95 | |
| Channeladvisor | 0.4 | $5.5M | 557k | 9.94 | |
| ArQule | 0.3 | $4.7M | 2.5M | 1.87 | |
| Sunesis Pharmaceuticals | 0.3 | $4.6M | 5.7M | 0.81 | |
| Catalyst Biosciences | 0.2 | $3.0M | 652k | 4.66 | |
| Paratek Pharmaceuticals | 0.2 | $2.4M | 125k | 19.00 | |
| Agile Therapeutics | 0.1 | $900k | 134k | 6.74 | |
| Akari Therapeutics | 0.0 | $645k | 27k | 23.98 |
